Close Menu

NEW YORK (GenomeWeb) – Agilent Technologies reported after the close of the market on Tuesday that its fiscal second quarter revenues rose 3 percent year over year.

For the three months ended April 30, the firm said total revenues rose to $1.24 billion from $1.21 billion in Q2 2018, missing the Wall Street analysts' average estimate of $1.27 billion. The company said core revenues grew 4 percent in Q2.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

University of Virginia researchers are exploring a genetic risk test to gauge type 1 diabetes risk, NPR reports.

In PNAS this week: researchers compare two high-grade neuroendocrine lung cancers, height among ancient Europeans, and more.

In PLOS this week: preconception carrier screening program results, comparative genomics-based analysis of Elizabethkingia meningoseptica, and more.

Canadian regulators are beginning to share information from new drug studies, Undark reports.